首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Synthesis and 5-HT(1A), 5-HT(2A) receptor activity of new beta-tetralonohydantoins.
【24h】

Synthesis and 5-HT(1A), 5-HT(2A) receptor activity of new beta-tetralonohydantoins.

机译:合成和5-HT(1A),5-HT(2A)受体活性的新的beta-tetralonohydantoins。

获取原文
获取原文并翻译 | 示例
           

摘要

A series of new 3-[4-(4-arylpiperazinyl)-butyl]-beta-tetralonohydantoins (8a-13a) were synthesized. The compounds exhibited high affinity for 5-HT(1A) receptors (K(i)=6 to 55 nM) combined with moderate-to-high 5-HT(2A) receptor affinities (K(i)=45 to 213 nM). The results of in vivo studies indicated that of the compounds tested, 3-[4-(4-phenylpiperazinyl)-butyl-beta-tetralonohydantoin (8a) showed features of full (pre- and postsynaptic) 5-HT(1A) receptor agonists, whereas compounds 9a-13a behaved like antagonists of postsynaptic 5-HT(1A) receptors; additionally, compound 13a produced an effect characteristic of presynaptic 5-HT(1A) receptor agonists. Moreover, compounds 8a and 10a-13a exhibited properties of 5-HT(2A) receptor antagonists. Due to the most interesting 5-HT(1A)/5-HT(2A) functional profile compounds 8a and 13a were further tested for their potential psychotropic activity. In fact, compound 8a (but not 13a) showed diazepam-like anxiolytic activity and behaved like a weak antidepressant.
机译:合成了一系列新的3- [4-(4-芳基哌嗪基)-丁基]-β-四氢呋喃丹酮(8a-13a)。这些化合物对5-HT(1A)受体(K(i)= 6至55 nM)表现出高亲和力,并具有中等至较高的5-HT(2A)受体亲和力(K(i)= 45至213 nM) 。体内研究结果表明,在所测试的化合物中,3- [4-(4-苯基哌嗪基)-丁基-β-四氢邻苯二酚尿苷(8a)显示出完整的(突触前和突触后)5-HT(1A)受体激动剂的特征。 ,而化合物9a-13a的行为类似于突触后5-HT(1A)受体的拮抗剂;此外,化合物13a产生了突触前5-HT(1A)受体激动剂的特有效应。此外,化合物8a和10a-13a表现出5-HT(2A)受体拮抗剂的特性。由于最有趣的5-HT(1A)/ 5-HT(2A)功能性化合物,化合物8a和13a的潜在精神活性得到了进一步测试。实际上,化合物8a(而非13a)显示出地西di样的抗焦虑活性,并表现为弱的抗抑郁药。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号